Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016 (2016), Article ID 2909210, 5 pages
http://dx.doi.org/10.1155/2016/2909210
Clinical Study

n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes

1Institute of Nutrition and Functional Foods, Laval University, Quebec City, QC, Canada G1V 0A6
2CHUQ Research Center, Laval University, Quebec City, QC, Canada G1V 4G2

Received 15 January 2016; Accepted 14 February 2016

Academic Editor: Bernard Portha

Copyright © 2016 André J. Tremblay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. N. Ginsberg, “Insulin resistance and cardiovascular disease,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 453–458, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. W. S. Harris, Y. Park, and W. L. Isley, “Cardiovascular disease and long-chain omega-3 fatty acids,” Current Opinion in Lipidology, vol. 14, no. 1, pp. 9–14, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. H. M. Roche and M. J. Gibney, “Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state,” Lipids, vol. 34, supplement, pp. S259–S265, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. J.-C. Hogue, B. Lamarche, A. J. Tremblay, J. Bergeron, C. Gagné, and P. Couture, “Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes,” Journal of Lipid Research, vol. 48, no. 6, pp. 1336–1342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Park and W. S. Harris, “Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance,” Journal of Lipid Research, vol. 44, no. 3, pp. 455–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Kesavulu, B. Kameswararao, C. Apparao, E. G. T. V. Kumar, and C. V. Harinarayan, “Effect of ω-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients,” Diabetes and Metabolism, vol. 28, no. 1, pp. 20–26, 2002. View at Google Scholar · View at Scopus
  7. R. M. McManus, J. Jumpson, D. T. Finegood, M. T. Clandinin, and E. A. Ryan, “A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes,” Diabetes Care, vol. 19, no. 5, pp. 463–467, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Fumeron, L. Brigant, V. Ollivier et al., “n-3 polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men,” The American Journal of Clinical Nutrition, vol. 54, no. 1, pp. 118–122, 1991. View at Google Scholar · View at Scopus
  9. C. Jeppesen, K. Schiller, and M. B. Schulze, “Omega-3 and omega-6 fatty acids and type 2 diabetes,” Current Diabetes Reports, vol. 13, no. 2, pp. 279–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Hartweg, A. J. Farmer, R. R. Holman, and A. Neil, “Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes,” Current Opinion in Lipidology, vol. 20, no. 1, pp. 30–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. J. Nestel, W. E. Connor, M. F. Reardon, S. Connor, S. Wong, and R. Boston, “Suppression by diets rich in fish oil of very low density lipoprotein production in man,” The Journal of Clinical Investigation, vol. 74, no. 1, pp. 82–89, 1984. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ouguerram, C. Maugeais, J. Gardette, T. Magot, and M. Krempf, “Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects,” British Journal of Nutrition, vol. 96, no. 1, pp. 100–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. W. S. Harris, W. E. Connor, D. R. Illingworth, D. W. Rothrock, and D. M. Foster, “Effects of fish oil on VLDL triglyceride kinetics in humans,” Journal of Lipid Research, vol. 31, no. 9, pp. 1549–1558, 1990. View at Google Scholar · View at Scopus
  14. S.-H. Wong, E. A. Fisher, and J. B. Marsh, “Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoprotein in HepG2 cells,” Arteriosclerosis, vol. 9, no. 6, pp. 836–841, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Parks and L. L. Rudel, “Effect of fish oil on atherosclerosis and lipoprotein metabolism,” Atherosclerosis, vol. 84, no. 2-3, pp. 83–94, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Levy, S. Spahis, E. Ziv et al., “Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids,” Diabetologia, vol. 49, no. 8, pp. 1937–1945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Hassanali, B. N. Ametaj, C. J. Field, S. D. Proctor, and D. F. Vine, “Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat,” Diabetes, Obesity and Metabolism, vol. 12, no. 2, pp. 139–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Chan, P. H. R. Barrett, and G. F. Watts, “Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders,” Current Opinion in Lipidology, vol. 17, no. 1, pp. 28–36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. M. Balk, A. H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, and J. Lau, “Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review,” Atherosclerosis, vol. 189, no. 1, pp. 19–30, 2006. View at Publisher · View at Google Scholar · View at Scopus